Literature DB >> 12951679

Role of cytology in the diagnosis of Barrett's esophagus and associated neoplasia.

Reda S Saad1, Laura K Mahood, Karen M Clary, Yulin Liu, Jan F Silverman, Stephen S Raab.   

Abstract

We studied 327 consecutive paired esophageal biopsies and brushing specimens obtained during the same endoscopic session to evaluate the role of cytology for the diagnosis of Barrett's esophagus (BE) and/or surveillance for associated dysplasia. A diagnosis of BE was based on the cytologic presence of goblet cells. Cases were reviewed and categorized into: 1) benign esophageal lesions (125 cases), with 48 cases of Candida (32 cases diagnosed by both techniques and 16 diagnosed only by cytology), 3 cases of herpes simplex with only 1 case diagnosed by cytology, and 74 cases of inflammation and/or repair; 2) benign BE (141 cases), with 74 cases (52%) diagnosed by both techniques, 11 cases by cytology only (8%), and 56 cases (40%) by histology only; 3) low-grade dysplasia (LGD, 30 cases), with 5 cases (17%) diagnosed with both specimens, one case (3%) by cytology only, and 24 cases (80%) by histology only; 4) high-grade dysplasia (HGD, 10 cases), with 8 cases (80%) diagnosed with both specimens, 1 case (10%) by cytology, and 1 case (10%) by histology; and 5) carcinomas (23 cases), with 20 cases (87%) diagnosed with both specimens, 2 cases (9%) by cytology only, and 1 case (4%) by histology only. Our results support the high degree of diagnostic accuracy of cytology for the diagnosis of Barrett's-associated HGD and/or carcinoma, and moderate sensitivity for BE. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12951679     DOI: 10.1002/dc.10334

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

1.  A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus.

Authors:  Emily G Barr Fritcher; Shannon M Brankley; Benjamin R Kipp; Jesse S Voss; Michael B Campion; Larry E Morrison; Mona S Legator; Lori S Lutzke; Kenneth K Wang; Thomas J Sebo; Kevin C Halling
Journal:  Hum Pathol       Date:  2008-07-07       Impact factor: 3.466

2.  Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma.

Authors:  Zhongren Zhou; Irina Kalatskaya; Donna Russell; Norman Marcon; Maria Cirocco; Paul M Krzyzanowski; Cathy Streutker; Hua Liang; Virginia R Litle; Tony E Godfrey; Lincoln Stein
Journal:  Clin Exp Gastroenterol       Date:  2019-05-15

Review 3.  Towards screening Barrett's oesophagus: current guidelines, imaging modalities and future developments.

Authors:  Ishaan Maitra; Ravindra Sudhachandra Date; Francis Luke Martin
Journal:  Clin J Gastroenterol       Date:  2020-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.